Effectiveness, safety, and acceptability of post-placental insertion of GyneFix postpartum intrauterine device among women undergoing cesarean section: A multicenter prospective cohort study in China 1
Yan Che,Gui-Fang Hou,Hong-Ping Zhang,Heng Yang,Shu-Juan Lin,Tao Gan,Wei-Hua Yang,Chun-Hui Shi,Wei-Juan Ren,Ying-Qin Xu,Bao-Ming Yin,Ting-Ting Chen,Yu-Jie Gan,Yuan Zhang,Yan Zhang,Li-Nan Cheng
DOI: https://doi.org/10.1016/j.contraception.2023.109999
IF: 3.051
2023-02-28
Contraception
Abstract:OBJECTIVE To assess the effectiveness, safety, and acceptability of post-placental insertion of GyneFix postpartum intrauterine device (PPIUD) in women undergoing cesarean section (C-section). STUDY DESIGN We conducted a prospective cohort study at 14 hospitals in four eastern coastal provinces of China between September, 2017, and November, 2020. A total of 470 women who underwent C-section and consented to the post-placental insertion of GyneFix PPIUD were enrolled, and 400 completed the 12-month follow-up. Participants were interviewed in the wards after delivery and followed up at 42 days, and months 3, 6, and 12 after delivery. We used Pearl Index to measure the rate of contraceptive failure, life table method to measure the rate of PPIUD discontinuation, including IUD expulsion, and Cox regression model to explore risk factors associated with discontinuation of the device. RESULTS Nine pregnancies were detected during the first year after GyneFix PPIUD insertion, seven were due to device expulsion and two occurred with PPIUD in situ . The PIs for overall 1-year pregnancy rate and pregnancies with IUD in situ were 2.3 (95% CI: 1.1–4.4) and 0.5 (95% CI: 0.1–1.9), respectively. The 6-, and 12-month cumulative expulsion rates for PPIUD expulsion were 6.3% and 7.6%, respectively. The overall 1-year continuation rate was 86.6% (95% CI: 83.3–89.8). We did not identify any patient with insertion failure, uterine perforation, pelvic infection, or excess bleeding due to GyneFix PPIUD insertion. Women's age, education, occupation, previous history of C-section, parity, and breastfeeding were not associated with removal of GyneFix PPIUD in the first year of use. Conclusions Post-placental insertion of GyneFix PPIUD is effective, safe, and acceptable for women undergoing C-section. Expulsion is the most common reason for GyneFix PPIUD discontinuation and pregnancy. The expulsion rate for GyneFix PPIUD is lower than framed IUDs but more evidence is needed for a firm verdict.
obstetrics & gynecology